Skip to content

Cases — 4332617

1 recorded connections shown. Select a record, office or person to follow its source references.

Start with
and connect to

Browse all held record sources

Zoom to read. Drag to explore. Select a connection.

Cases — 4332617

Cases · As of Oct 2, 2026

Cases — 4332617: 1 outgoing connections shown. Point at anyone to see how they are linked.Showing bounded source connections. Dates come from the held records; missing relationships remain unknown.

The source record

As of Oct 2, 2026.

Activity name
JOHNSON MATTHEY PHARMACEUTICAL MATERIALS INC
Case number
01-2012-3017
Case name
JOHNSON MATTHEY PHARMACEUTICAL MATERIALS INC
Region code
01
Fiscal year
2012
Activity type code
AFR
Activity type desc
Administrative - Formal
Activity status code
CLS
Activity status desc
Closed
Activity status date
2012-08-29
Lead agency
EPA
Case status date
2012-08-29
Enforcement outcome code
ECP
Enforcement outcome desc
Final Order With Penalty
Voluntary self disclosure
false
Multimedia flag
false
Summary text
Region I Settles EPCRA Case Against Johnson Matthey Pharmeutical Materials, Inc. of North Andover, Mass. On August 29, 2012, Region 1 filed a Consent Agreement and Final Order (“CAFO”) that simultaneously initiated and resolved an alleged violation of Section 313 of the Emergency Planning and Community Right-to-Know Act (“EPCRA”) by Johnson Matthey Pharmaceuticals Services of North Andover, Massachusetts. The CAFO alleged that the facility failed to submit the required Toxic Release Inventory Form for the chemical acetonitrile in 2009 and 2010 (forms for other toxic chemicals used at the facility were correctly submitted). This action is part of OECA’s EPCRA 313 non-filer initiative. Pursuant to the CAFO, Johnson Matthey Pharmaceutical Materials, Inc. will pay a civil penalty of $8,190.
Created at
2026-10-02T02:02:59.061315+00:00
Updated at
2026-10-02T02:02:59.061315+00:00